Evolus (EOLS) Revenue Growth (1y) (2020 - 2026)
Evolus (EOLS) Revenue Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.34% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 2.91% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -1.62% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 6.98% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 42.25% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 14.92% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -87.11% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 3.77% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.23% |
| 10 | Evolus | 437.40 Mn | 387.61 Mn | 48.90 Mn | 6.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.74% |
| Dec 31, 2025 | 14.38% |
| Sep 30, 2025 | 12.90% |
| Jun 30, 2025 | 3.70% |
| Mar 31, 2025 | 15.49% |
| Dec 31, 2024 | 29.42% |
| Sep 30, 2024 | 22.12% |
| Jun 30, 2024 | 35.59% |
| Mar 31, 2024 | 42.21% |
| Dec 31, 2023 | 39.76% |
| Sep 30, 2023 | 47.55% |
| Jun 30, 2023 | 32.78% |
| Mar 31, 2023 | 23.04% |
| Dec 31, 2022 | 25.94% |
| Sep 30, 2022 | 27.07% |
| Jun 30, 2022 | 42.40% |
| Mar 31, 2022 | 177.00% |
| Dec 31, 2021 | 68.43% |
| Sep 30, 2021 | 51.05% |
| Jun 30, 2021 | 234.33% |